vs

Side-by-side financial comparison of Aptorum Group Ltd (APM) and LGL GROUP INC (LGL). Click either name above to swap in a different company.

LGL GROUP INC is the larger business by last-quarter revenue ($803.0K vs $442.8K, roughly 1.8× Aptorum Group Ltd). LGL GROUP INC runs the higher net margin — -3.4% vs -63.8%, a 60.4% gap on every dollar of revenue.

Aptorum Group Ltd is a global biopharmaceutical enterprise dedicated to researching, developing and commercializing innovative therapeutic and diagnostic solutions. Its core focus areas cover infectious diseases, women’s health, and rare disorders, with key markets spanning North America and the Asia-Pacific region.

LGL Group Inc is a global electronic components manufacturer that designs, produces and markets high-performance frequency control products, radio frequency components and integrated circuit solutions. It primarily serves aerospace, defense, telecommunications, industrial and medical technology end markets, supplying specialized parts with strict reliability requirements.

APM vs LGL — Head-to-Head

Bigger by revenue
LGL
LGL
1.8× larger
LGL
$803.0K
$442.8K
APM
Higher net margin
LGL
LGL
60.4% more per $
LGL
-3.4%
-63.8%
APM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APM
APM
LGL
LGL
Revenue
$442.8K
$803.0K
Net Profit
$-282.5K
$-27.0K
Gross Margin
Operating Margin
-52.6%
14.8%
Net Margin
-63.8%
-3.4%
Revenue YoY
23.0%
Net Profit YoY
-113.4%
EPS (diluted)
$-0.04
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APM
APM
LGL
LGL
Q4 25
$442.8K
$803.0K
Q3 25
$208.8K
$661.0K
Q2 25
$491.0K
Q1 25
$498.0K
Q4 24
$653.0K
Q3 24
$650.0K
Q2 24
$531.0K
Q1 24
$392.0K
Net Profit
APM
APM
LGL
LGL
Q4 25
$-282.5K
$-27.0K
Q3 25
$-614.0K
$772.0K
Q2 25
$-51.0K
Q1 25
$-6.0K
Q4 24
$202.0K
Q3 24
$72.0K
Q2 24
$137.0K
Q1 24
$21.0K
Operating Margin
APM
APM
LGL
LGL
Q4 25
-52.6%
14.8%
Q3 25
-71.9%
18.2%
Q2 25
-6.3%
Q1 25
8.2%
Q4 24
37.5%
Q3 24
21.2%
Q2 24
44.6%
Q1 24
20.2%
Net Margin
APM
APM
LGL
LGL
Q4 25
-63.8%
-3.4%
Q3 25
-294.0%
116.8%
Q2 25
-10.4%
Q1 25
-1.2%
Q4 24
30.9%
Q3 24
11.1%
Q2 24
25.8%
Q1 24
5.4%
EPS (diluted)
APM
APM
LGL
LGL
Q4 25
$-0.04
$-0.02
Q3 25
$-0.09
$0.14
Q2 25
$-0.01
Q1 25
$0.00
Q4 24
$0.05
Q3 24
$0.01
Q2 24
$0.02
Q1 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APM
APM
LGL
LGL
Cash + ST InvestmentsLiquidity on hand
$3.5M
$41.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$23.1M
$43.5M
Total Assets
$18.7M
$46.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APM
APM
LGL
LGL
Q4 25
$3.5M
$41.5M
Q3 25
$56.8K
$41.6M
Q2 25
$41.8M
Q1 25
$41.9M
Q4 24
$41.6M
Q3 24
$41.6M
Q2 24
$41.1M
Q1 24
$40.9M
Stockholders' Equity
APM
APM
LGL
LGL
Q4 25
$23.1M
$43.5M
Q3 25
$22.5M
$39.8M
Q2 25
$39.1M
Q1 25
$39.2M
Q4 24
$39.2M
Q3 24
$39.0M
Q2 24
$38.9M
Q1 24
$38.8M
Total Assets
APM
APM
LGL
LGL
Q4 25
$18.7M
$46.8M
Q3 25
$17.6M
$43.3M
Q2 25
$43.0M
Q1 25
$43.3M
Q4 24
$43.1M
Q3 24
$42.5M
Q2 24
$42.2M
Q1 24
$42.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APM
APM
LGL
LGL
Operating Cash FlowLast quarter
$-145.9K
$-355.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APM
APM
LGL
LGL
Q4 25
$-145.9K
$-355.0K
Q3 25
$-484.3K
$275.0K
Q2 25
$-190.0K
Q1 25
$340.0K
Q4 24
$-17.0K
Q3 24
$528.0K
Q2 24
$203.0K
Q1 24
$160.0K
Cash Conversion
APM
APM
LGL
LGL
Q4 25
Q3 25
0.36×
Q2 25
Q1 25
Q4 24
-0.08×
Q3 24
7.33×
Q2 24
1.48×
Q1 24
7.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons